Concepedia
Statistics
Publications
8
Citations
659
H-Index
Active since
2017
Affiliations
Universitätsklinikum Erlangen(Current)
Friedrich-Alexander-Universität Erlangen-Nürnberg
Paracelsus Medizinische Privatuniversität
IPPMed (Germany)
Marina V. Karg is an author at Universitätsklinikum Erlangen specializing in medicine, clinical pharmacology, and diabetes mellitus.
Publications per year
2017–2023
SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial
Marina V. Karg, Agnes Bosch, Dennis Kannenkeril et al. · Cardiovascular Diabetology · 2018 · 182 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +17
A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation
Christian Ott, Agnes Jumar, Kristina Striepe et al. · Cardiovascular Diabetology · 2017 · 147 citations · Full text
How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical trial
Agnes Bosch, Christian Ott, Susanne Jung et al. · Cardiovascular Diabetology · 2019 · 121 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +15
Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications
David E. Kandzari, Raymond R. Townsend, Kazuomi Kario et al. · Journal of the American College of Cardiology · 2023 · 116 citations
Pharmacy, Nephrology, Pharmacotherapy +17
Tissue sodium content in patients with type 2 diabetes mellitus
Dennis Kannenkeril, Marina V. Karg, Agnes Bosch et al. · Journal of Diabetes and its Complications · 2019 · 34 citations
Medicine, Endocrinology, Physiology +13
1–5 of 8